Potential safety concern for Guillain-Barré syndrome identified for Johnson & Johnson vaccine 10/20/2021 mediabest Health News (HealthDay)—Receipt of the Ad26.COV2.S (Janssen/Johnson & Johnson) COVID-19 vaccine is Read more